Cart
0

Cardiac Monitoring & Cardiac Rhythm Management Market by Product (Electrocardiogram (ECG) Devices, Implantable Loop Recorders (ILR), Cardiac Output Monitoring (COM) Devices, Event Monitors, Pacemakers, Cardiac Resynchronization Therapy (CRT) Devices, Defibrillators, and Ventricular Assist Devices (VADs)) and by End User (Hospitals & Clinics, Home Settings, and Ambulatory Surgical Centers (ASCs)) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Get 20% Free Customization In This Report
LI_161821
Pages: 318
Dec 2016 | 3209 Views
 
Author's : Deepa Tatkare
Tables: 103
Charts: 49
 

Cardiac Monitoring & Cardiac Rhythm Management Market Overview:

Global Cardiac Monitoring & Cardiac Rhythm Management Market size was valued at $19,397 million in 2015 and is expected to reach $32,216 million by 2022, growing at a CAGR of 7.6%. The volume market is poised to grow at a CAGR of 13.6% from 2016 to 2022. Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs, and certain genetic errors among others.

Get more information on this report : Request Sample Pages

The market is driven by factors such as growing incidence of cardiac disorders, technological advancements, patient awareness, and increasing number of unmet medical needs in developing and underdeveloped countries. Conversely, the market is hampered by limited insurance coverage options; high cost of these devices, especially in developing nations; and preference for drugs over treatment devices. However, the development of new MRI-labeled devices and growth opportunities in the emerging economies of Asia-Pacific and LAMEA regions are expected to provide opportunities for growth of cardiac monitoring & cardiac rhythm management industry during the forecast period.

Get more information on this report : Request Sample Pages

Cardiac monitoring & cardiac rhythm management industry includes a large number of small and large manufacturers at regional as well as global level. The market is consolidated with two large players namely General Electric Company (GE) and Koninklijke Philips N.V., These two players dominate the overall cardiac monitoring devices market.

Get more information on this report : Request Sample Pages

Segment Review:

The defibrillators segment accounted for the largest market share in 2015. Increasing adoption of technologically advanced defibrillators, growing demand for quality medical care, and high incidence of sudden cardiac arrest (SCA) and cardiovascular diseases (CVDs) are the drivers of the defibrillators market. In addition, increasing focus of public & private organizations and key market players on public access defibrillators, and increasing number of training & awareness programs across the globe fuel the market growth. Moreover, promoting innovation in next generation external defibrillators to improve safety and effectiveness, enhancing the ability of industry, identifying and addressing problems associated with devices by the FDA, and focusing on the SCA are anticipated to create lucrative opportunities for the global defibrillators market.

Get more information on this report : Request Sample Pages

Brazilian Cardiac Monitoring & Cardiac Rhythm Management Market, Snapshot

Increasing focus of market vendors on the emerging markets, namely Asia-Pacific and LAMEA regions, is expected to boost the market growth. For instance, key players, namely GE Healthcare and Philips Healthcare have heavily invested in the development of their infrastructure, such as R&D centers and production facilities in the emerging countries in the last few years to provide low-cost treatment devices in this region. This has boosted cardiac monitoring market in the region. The market in Brazil is primarily driven by the rising incidence of cardiac disorders coupled with rapidly growing geriatric patient population. This is evident from an article published in the Journal of the American College of Cardiology 2013, which stated that the estimated prevalence rate of heart failure in Latin America ranges from 64 to 69%. Growth in cardiac rhythm management devices market would also lead to growth in cardiac monitoring devices market as a patient with rhythm disorder would require monitoring as well. The diagnosis of cardiac abnormalities, monitoring, and treatment is expected to be a lucrative area of investment for market players in future, owing to the increasing number of technological advancements in cardiac monitoring & cardiac rhythm management devices. This is expected to provide stellar opportunities to the market growth in the future.

Top Impacting Factors

Growing Incidence of Cardiac Disorders

Geriatric population face various cardiac problems, which leads to heart failures, thereby increasing the demand for pacemakers, ventricular assisted devices (VADs), electrocardiogram (ECG), and implantable cardioverter defibrillators (ICDs). The use of these devices to treat cardiac diseases has increased due to the rise in fatalities due to heart failure and other cardiac abnormalities across the globe. Therefore, this factor has a prominent impact on the growth of CM and CRM devices market.

Technological Advancements

The impact of this factor has a significant effect on increasing the adoption of novel devices, as the market is highly driven by the technological innovation implemented in this sector. Moreover, increase in cardiac diseases is projected to boost the demand for effective treatment solutions. Thus, this factor is expected to continue to have a significant impact on the growth of CM and CRM devices market during the forecast period.

Increasing Patient Awareness

The impact of this factor has affected the market growth in emerging economies, as the adoption of advanced treatment devices is low these regions. There are several innovative and implantable-assisted products available in the market; however, the surgeons and patients in the underdeveloped economies are not well-aware about the devices, thereby hindering the market growth. The impact of this factor is likely to reduce in the future, as manufacturers have collaborated with government hospitals to spread awareness about novel cardiac monitoring & cardiac rhythm management devices.

Presence of High-Unmet Medical Needs

The key players of the market have launched technologically advanced devices in the developing and underdeveloped economies. For instance, Boston Scientific Corporation have tried to obtain a regulatory approval for its S-ICD system to market it across Asia, Middle East, and Africa. The key manufacturers have collaborated with government bodies to provide effective and innovative cardiac solutions. In addition, the government and private sector authorities have strived to provide favorable reimbursement schemes for treatment of cardiac disorders in developing and underdeveloped economies. Moreover, the increase in awareness, disposable incomes, and approvals for technologically advanced devices are expected to further continue to have huge impact on the market during the forecast period.

Limited Insurance Coverage and High Cost of Devices

Technologically advanced cardiac monitoring & cardiac rhythm management devices, such as wireless pacemakers, leadless pacemakers, MRI compatible devices, biocompatible materials, miniaturized devices, and durable batteries, are readily available in the market, especially in developed regions, for the treatment of heart ailments. However, high cost of these devices has a negative impact on the market growth, due to their lower adoption and less number of procedures involving the usage of these devices. The adoption of these devices is low in developing and underdeveloped economies, owing to the high cost of these. However, the impact of this factor is expected to decrease in the near future, as the companies plan to develop affordable cardiac monitoring & cardiac rhythm management devices.

Preference for Drugs

The impact of this factor is currently affecting the market growth, as the adoption of these devices depends on consumer preferences and behavior. However, the impact of this factor is expected to reduce in the near future, as the manufacturers have collaborated with government hospitals to spread awareness about the current treatment patterns with improved devices. In addition, the impact of this factor is projected to be low on the market growth, as drugs cannot be used for heart monitoring.

Key Benefits:

  • The study provides an in-depth analysis of cardiac monitoring & cardiac rhythm management market along with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis for the period of 20142022 to enable stakeholders to capitalize on the prevailing opportunities in CM and CRM devices market.
  • Extensive analysis of the market based on product helps in understanding the type of devices used for treating blockages associated with chronic diseases.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • Comprehensive analysis of all geographical regions helps in determining the prevailing opportunities in these regions.
  • Key market players and their strategies are analyzed to understand the competitive outlook of the global market.
  • Extensive analysis of the market is conducted by following key product positioning and monitoring the top contenders within the market framework.

Cardiac Monitoring & Cardiac Rhythm Management Market Key Segments:

By Product

  • Electrocardiogram (ECG) Devices
    • ECG by Type
      • Resting ECG
      • Stress ECG
      • Holter Monitors
        • Wired
        • Wireless
    • ECG by Lead
      • Single Lead
      • 3-6 Lead
      • 12 Lead
  • Implantable Loop Recorders (ILR)
  • Cardiac Output Monitoring (COM) Devices
    • Minimally Invasive COM Devices
    • Noninvasive COM Devices
  • Event Monitors
    • By Type
      • Pre-symptom
      • Post-symptom
    • By Technology
      • Manual Event Monitors
      • Autodetect Monitors
  • Pacemakers
    • Implantable Pacemakers
    • External Pacemakers
  • Cardiac Resynchronization Therapy (CRT) Devices
    • CRT-P (CRT with Pacemaker Function)
    • CRT-D (CRT with Pacemaker and ICD Function)
  • Defibrillator
    • Implantable Cardioverter Defibrillators (ICDs)
      • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
      • Dual-chamber ICDs
      • Single-chamber ICDs
    • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
  • External Defibrillator
    • Manual External Defibrillator
    • Automated External Defibrillator (AEDs)
      • Semiautomated External Defibrillator
      • Fully Automated External Defibrillator
    • Wearable Cardioverter Defibrillator (WCDs)
  • Ventricular Assist Devices (VADs)
    • Left Ventricular Assist Device (LVAD)
    • Right Ventricular Assist Device (RVAD)
    • Biventricular Assist Device (BIVAD)

By End User

  • Hospitals & Clinics
  • Home Settings
  • Ambulatory Surgical Centers (ASCs)

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Malaysia
    • New Zealand
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Egypt
    • Rest of LAMEA

List of Key Players Profiled in the Report

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • General Electric Company (GE)
  • Hill-Rom Holdings, Inc.
  • Jarvik Heart, Inc.
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic plc
  • Nihon Kohden Corporation
  • ReliantHeart Inc.
  • SCHILLER AG
  • St. Jude Medical, Inc.

List of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request)

  • Siemens AG
  • 3M Company
  • Asahi Kasei Corporation
  • Stryker Corporation
  • Mortara Instrument, Inc.
  • OSI Systems, Inc.
  • Cardionet Inc.
 

Chapter: 1 INTRODUCTION

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2015
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Growing incidences of cardiac disorders
3.4.1.2. Technological advancements
3.4.1.3. Increasing patient awareness
3.4.1.4. Presence of high-unmet medical needs

3.4.2. Restraints

3.4.2.1. Limited insurance coverage and high cost of devices
3.4.2.2. Preference for drugs

3.4.3. Opportunities

3.4.3.1. Lucrative opportunities in emerging economies
3.4.3.2. Development of new MRI-labeled devices

Chapter: 4 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ELECTROCARDIOGRAM (ECG) DEVICES

4.2.1. By type

4.2.1.1. Resting ECG devices
4.2.1.2. Stress ECG devices
4.2.1.3. ECG Holter monitors

4.2.1.3.1. Wired Holter monitors
4.2.1.3.2. Wireless Holter monitors

4.2.2. By lead type

4.2.2.1. Single lead
4.2.2.2. 3-6 lead
4.2.2.3. 12-lead

4.2.3. Key market trends
4.2.4. Key growth factors and opportunities
4.2.5. Market size and forecast

4.3. IMPLANTABLE LOOP RECORDER (ILR)

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. CARDIAC OUTPUT MONITORING DEVICES (COM)

4.4.1. Minimally invasive COM devices
4.4.2. Non-invasive COM devices
4.4.3. Key market trends
4.4.4. Key growth factors and opportunities
4.4.5. Market size and forecast

4.5. EVENT MONITORS

4.5.1. By type

4.5.1.1. Pre-symptom
4.5.1.2. Post-symptom

4.5.2. By technology

4.5.2.1. Manual event monitors
4.5.2.2. Autodetect monitors

4.5.3. Key market trends
4.5.4. Key growth factors and opportunities
4.5.5. Market size and forecast

4.6. PACEMAKERS

4.6.1. Implantable pacemakers
4.6.2. External pacemakers
4.6.3. Key market trends
4.6.4. Key growth factors and opportunities
4.6.5. Market size and forecast

4.7. CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES

4.7.1. CRT-P (CRT with pacemaker function)
4.7.2. CRT-D (CRT with pacemaker and ICD function)
4.7.3. Key market trends
4.7.4. Key growth factors and opportunities
4.7.5. Market size and forecast

4.8. DEFIBRILLATORS

4.8.1. Implantable cardioverter defibrillators (ICDs)

4.8.1.1. Transvenous implantable cardioverter defibrillator (T-ICDs)

4.8.1.1.1. Single-chamber ICDs
4.8.1.1.2. Dual-chamber ICDs

4.8.1.2. Subcutaneous implantable cardioverter defibrillator (S-ICDs)

4.8.2. External defibrillator

4.8.2.1. Manual external defibrillator
4.8.2.2. Automated external defibrillator (AEDs)

4.8.2.2.1. Semi-automated external defibrillator
4.8.2.2.2. Fully automated external defibrillator

4.8.2.3. Wearable cardioverter defibrillator (WCDs)

4.8.3. Key market trends
4.8.4. Key growth factors and opportunities
4.8.5. Market size and forecast

4.9. VENTRICULAR ASSIST DEVICES (VADS)

4.9.1. Left ventricular assist device (LVAD)
4.9.2. Right ventricular assist device (RVAD)
4.9.3. Biventricular assist device (BIVAD)
4.9.4. Key market trends
4.9.5. Key growth factors and opportunities
4.9.6. Market size and forecast

Chapter: 5 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET BY END USER

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. HOSPITALS & CLINICS

5.2.1. Market size and forecast

5.3. HOME SETTINGS

5.3.1. Market size and forecast

5.4. AMBULATORY SURGICAL CENTERS (ASCS)

5.4.1. Market size and forecast

Chapter: 6 CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.
6.2.5. Canada
6.2.6. Mexico

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany
6.3.5. France
6.3.6. UK
6.3.7. Italy
6.3.8. Spain
6.3.9. Switzerland
6.3.10. Rest of Europe

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan
6.4.5. China
6.4.6. India
6.4.7. Malaysia
6.4.8. Australia
6.4.9. New Zealand
6.4.10. Rest of Asia-Pacific

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil
6.5.5. South Africa
6.5.6. Egypt
6.5.7. Rest of LAMEA

Chapter: 7 COMPANY PROFILES

7.1. ABIOMED, INC.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Business performance
7.1.5. Key strategic moves & developments

7.2. BERLIN HEART GMBH

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Key strategic moves & developments

7.3. BIOTRONIK SE & CO. KG

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Key strategic moves & developments

7.4. BOSTON SCIENTIFIC CORPORATION

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Key strategic moves & developments

7.5. CARDIAC SCIENCE CORPORATION

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Key strategic moves and developments

7.6. GENERAL ELECTRIC COMPANY

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Business performance
7.6.5. Key strategic moves & developments

7.7. HILL-ROM HOLDINGS, INC.

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Business performance
7.7.5. Key strategic moves & developments

7.8. JARVIK HEART, INC.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Key strategic moves & developments

7.9. KONINKLIJKE PHILIPS N.V.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Business performance
7.9.5. Key strategic moves & developments

7.10. LIVANOVA PLC

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Business performance
7.10.5. Key strategic moves & developments

7.11. MEDTRONIC PLC

7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Operating business segments
7.11.4. Business performance
7.11.5. Key strategic moves & developments

7.12. NIHON KOHDEN CORPORATION

7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Operating business segments
7.12.4. Business performance
7.12.5. Key strategic moves and developments

7.13. RELIANTHEART, INC.

7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Operating business segments
7.13.4. Key strategic moves & developments

7.14. SCHILLER AG

7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Operating business segments
7.14.4. Key strategic moves & developments

7.15. ST. JUDE MEDICAL, INC.

7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Operating business segments
7.15.4. Business performance
7.15.5. Key strategic moves & developments

LIST OF TABLES

TABLE 1. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 2. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY TYPE (THOUSAND UNITS), 2014-2022
TABLE 3. GLOBAL ECG DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 4. GLOBAL ECG DEVICES MARKET, BY LEAD ($MILLION), 2014-2022
TABLE 5. GLOBAL HOLTER MONITORS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 6. GLOBAL ECG DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 7. GLOBAL ECG DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 8. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 9. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET, BY END USER ($MILLION), 2014-2022
TABLE 10. GLOBAL CARDIAC OUTPUT MONITORING DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 11. GLOBAL CRADIAC OUTPUT MONITORING DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 12. GLOBAL CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 13. GLOBAL EVENT MONITORS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 14. GLOBAL EVENT MONITORS MARKET, BY TECHNOLOGY ($MILLION), 2014-2022
TABLE 15. GLOBAL EVENT MONITORS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 16. GLOBAL EVENT MONITORS MARKET, BY END USER ($MILLION), 2014-2022
TABLE 17. GLOBAL PACEMAKERS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 18. GLOBAL PACEMAKERS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 19. GLOBAL PACEMAKERS MARKET, BY END USER ($MILLION), 2014-2022
TABLE 20. GLOBAL CARDIC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 21. GLOBAL CARDIC RESYNCHRONIZATION THERAPY (CRT) DEVICES MARKET, BY REGION ($MILLION), 2014-2022
TABLE 22. GLOBAL CARDIC RESYNCHRONIZATION THERAPY (CRT)DEVICES MARKET, BY END USER ($MILLION), 2014-2022
TABLE 23. GLOBAL DEFIBRILLATORS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 24. GLOBAL DEFIBRILLATORS MARKET, BY TYPE (THOUSAND UNITS), 2014-2022
TABLE 25. GLOBAL ICDS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 26. GLOBAL EXTERNAL DEFIBRILLATORS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 27. GLOBAL AUTOMATED EXTERNAL DEFIBRILLATORS (AED) MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 28. GLOBAL DEFIBRILLATORS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 29. GLOBAL DEFIBRILLATORS MARKET, BY END USER ($MILLION), 2014-2022
TABLE 30. GLOBAL VENTRICULAR ASSIST DEVICE (VADS) MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 31. GLOBAL VENTRICULAR ASSIST DEVICE (VADS) MARKET, BY REGION ($MILLION), 2014-2022
TABLE 32. GLOBAL VENTRICULAR ASSIST DEVICE (VADS) MARKET, BY END USER ($MILLION), 2014-2022
TABLE 33. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 34. HOSPITALS & CLINICS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 35. HOME SETTINGS CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 36. AMBULATORY SURGICAL CENTERS (ASCS) CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 37. GLOBAL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY REGION ($MILLION), 2014-2022
TABLE 38. NORTH AMERICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 39. NORTH AMERICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 40. NORTH AMERICA ECG DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 41. NORTH AMERICA IMPLANTABLE LOOP RECORDERS (ILR) MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 42. NORTH AMERICA CARDIAC OUTPUT MONITORING (COM) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 43. NORTH AMERICA EVENT MONITORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 44. NORTH AMERICA PACEMAKERS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 45. NORTH AMERICA CARDIAC RESYNCHRONISATION THERAPY (CRT) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 46. NORTH AMERICA DEFIBRILLATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 47. NORTH AMERICA VADS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 48. EUROPE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 49. EUROPE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 50. EUROPE ECG DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 51. EUROPE IMPLANTABLE LOOP RECORDERS (ILR) MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 52. EUROPE CARDIAC OUTPUT MONITORING (COM) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 53. EUROPE EVENT MONITORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 54. EUROPE PACEMAKERS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 55. EUROPE CARDIAC RESYNCHRONISATION THERAPY (CRT) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 56. EUROPE DEFIBRILLATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 57. EUROPE VADS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 58. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 59. ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 60. ASIA-PACIFIC ECG DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 61. ASIA-PACIFIC IMPLANTABLE LOOP RECORDERS (ILR) MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 62. ASIA-PACIFIC CARDIAC OUTPUT MONITORING (COM) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 63. ASIA-PACIFIC EVENT MONITORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 64. ASIA-PACIFIC PACEMAKERS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 65. ASIA-PACIFIC CARDIAC RESYNCHRONISATION THERAPY (CRT) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 66. ASIA-PACIFIC DEFIBRILLATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 67. ASIA-PACIFIC VADS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 68. LAMEA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 69. LAMEA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET, BY END USER ($MILLION), 2014-2022
TABLE 70. LAMEA ECG DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 71. LAMEA IMPLANTABLE LOOP RECORDERS (ILR) MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 72. LAMEA CARDIAC OUTPUT MONITORING (COM) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 73. LAMEA EVENT MONITORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 74. LAMEA PACEMAKERS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 75. LAMEA CARDIAC RESYNCHRONISATION THERAPY (CRT) DEVICES MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 76. LAMEA DEFIBRILLATORS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 77. LAMEA VADS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 78. ABIOMED: COMPANY SNAPSHOT
TABLE 79. BERLIN HEART: COMPANY SNAPSHOT
TABLE 80. BIOTRONIK: COMPANY SNAPSHOT
TABLE 81. BIOTRONIK: OPERATING SEGMENTS
TABLE 82. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 83. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 84. CARDIAC SCIENCE CORPORATION: COMPANY SNAPSHOT
TABLE 85. CARDIAC SCIENCE CORPORATION: OPERATING SEGMENTS
TABLE 86. GE: COMPANY SNAPSHOT
TABLE 87. GE: OPERATING SEGMENTS
TABLE 88. HILL-ROM: COMPANY SNAPSHOT
TABLE 89. HILL-ROM: OPERATING SEGMENTS
TABLE 90. JARVIK HEART: COMPANY SNAPSHOT
TABLE 91. PHILIPS: COMPANY SNAPSHOT
TABLE 92. PHILIPS: OPERATING SEGMENTS
TABLE 93. LIVANOVA: COMPANY SNAPSHOT
TABLE 94. LIVANOVA: OPERATING SEGMENTS
TABLE 95. MEDTRONIC: COMPANY SNAPSHOT
TABLE 96. MEDTRONIC: OPERATING SEGMENTS
TABLE 97. NIHON KOHDEN: COMPANY SNAPSHOT
TABLE 98. NIHON KOHDEN: OPERATING SEGMENTS
TABLE 99. RELIANTHEART: COMPANY SNAPSHOT
TABLE 100. SCHILLER: COMPANY SNAPSHOT
TABLE 101. SCHILLER: PRODUCT CATEGORIES
TABLE 102. ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 103. ST. JUDE MEDICAL: PRODUCT CATEGORIES

LIST OF FIGURES

FIGURE 1. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET SHARE ANALYSIS, CARDIAC RHYTHM MANAGEMENT MARKET, 2015
FIGURE 9. MARKET SHARE ANALYSIS, CARDIAC MONITORING MARKET, 2015
FIGURE 10. TOP IMPACTING FACTORS: CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET
FIGURE 11. GLOBAL IMPLANTABLE LOOP RECORDERS MARKET ($MILLION), 2014-2022
FIGURE 12. GLOBAL CARDIAC OUTPUT MONITORING DEVICES MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 13. GLOBAL VENTRICULAR ASSIST DEVICE (VADS) MARKET, BY END USER ($MILLION), 2014-2022
FIGURE 14. U.S. CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 15. CANADA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 16. MEXICO CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 17. GERMANY CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 18. FRANCE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 19. UK CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 20. ITALY CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 21. SPAIN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 22. SWITZERLAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 23. REST OF EUROPE CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 24. JAPAN CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 25. CHINA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 26. INDIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 27. MALAYSIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 28. AUSTRALIA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 29. NEW ZEALAND CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 30. REST OF ASIA-PACIFIC CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 31. BRAZIL CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 32. SOUTH AFRICA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 33. EGYPT CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 34. REST OF LAMEA CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT MARKET ($MILLION), 2014-2022
FIGURE 35. ABIOMED: NET SALES, 2013-2015 ($MILLION)
FIGURE 36. BIOTRONIK: STRATEGY SHARE, (2014-2016), (%)
FIGURE 37. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2013-2015, ($MILLION)
FIGURE 38. BOSTON SCIENTIFIC: STRATEGY SHARE, (2014-2016) (%)
FIGURE 39. GE: NET SALES, 2013-2015, ($MILLION)
FIGURE 40. HILL-ROM: FINANCIALS
FIGURE 41. PHILIPS: NET SALES, 2013-2015, ($MILLION)
FIGURE 42. LIVANOVA: NET SALES, 2013-2015 ($MILLION)
FIGURE 43. LIVANOVA: STRATEGY SHARE, (2014-2016), (%)
FIGURE 44. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 45. MEDTRONIC: STRATEGY SHARE, (2014-2016),(%)
FIGURE 46. NIHON KOHDEN: FINANCIALS
FIGURE 47. RELIANTHEART: STRATEGY SHARE, (2014-2016), (%)
FIGURE 48. ST. JUDE MEDICAL: NET SALES, 2013-2015 ($MILLION)
FIGURE 49. ST. JUDE MEDICAL: STRATEGY SHARE, (2014-2016), (%)

 

Globally cardiac disorders constitute a high proportion of health and economic burden; hence monitoring of activities of the heart and management of normal heart rhythm is vital to ensure that the patient has a well-functioning heart. Therefore, the cardiac monitoring and cardiac rhythm management market will observe a significant rise in the upcoming years. These devices are used to cure and monitor several serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs, and certain genetic errors among others.

The rise in incidence of sudden cardiac arrest (SCA) has led to an increase in the use of defibrillators, thereby increasing the market share for defibrillators in the total market. In addition, increase in adoption of technologically advanced defibrillators, growth in demand for quality medical care, increase in focus of public organizations, private organizations, and key market players on public access defibrillators; and increase in number of training and awareness programs across the globe also lead to the growth of defibrillators market.

Cardiac monitoring is an essential part of treatment of any cardiac patient and ECG is one of first tests conducted during the examination of a patients heart. Therefore, ECG devices also occupy a significant share in the total market. In addition, ECG provides a cost-effective, minimally invasive method for the diagnosis of a variety of cardiac abnormalities; therefore, it is generally preferred by physicians and patients.

Geographically, the Asia-Pacific market offers lucrative growth opportunity due to increase in demand for advanced health care services in the emerging economies (such as India and China) and increase in prevalence of cardiac disorders coupled with rise in elderly population in these nations. Thus, the emerging markets have a huge potential for the market growth in the cardiac monitoring & cardiac rhythm management area.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Cardiac Monitoring & Cardiac Rhythm Management Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $4344
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4826
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5726
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6877
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9591
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo